0%
Exogenous Substances
14+
Days GF Release
IIa
Device Class
FUNdb
Clinical database
How It Works
From algorithm to treatment in four steps.
Control, repeatability, high growth factor concentration, and data-driven clinical support — in a single workflow.
1. Algorithm
FUNdb calculates optimal concentration based on the clinical case
2. Blood Draw
Venous sample under 60 ml — fully compliant with blood legislation
3. Centrifuge
Medifuge HQC — Class IIa automated separator with calibrated protocols
4. Treatment
CGF gel patch or injectable E-PRP ready for application
The Complete System
Three elements. One result.
Technology, devices and clinical data — integrated to maximize regenerative efficacy.
FUNdb — Digital dosing platform
Proprietary algorithm that calculates the exact protocol based on patient baseline. A complete clinical management platform.
Calculates optimal tube selection, centrifugation protocol and concentration based on patient parameters.
Every treatment logged. Longitudinal tracking and protocol optimization over time.
Structured reports for peer-reviewed publication. Multi-center data aggregation.
Patient data encrypted under European data protection standards.
Medifuge HQC — Class IIa
One of the very few centrifuges validated as a Class IIa medical device. Fully automated, self-disinfecting, OR-ready.
Class IIa CE certified
Fully compliant for sterile field use.
Precision dynamics
Calibrated ramps up to 3600 rpm. Autoclavable 135°C.
UV-C decontamination
Built-in reflected light. Thermal anti-static materials.
Pure Biology. Zero Additives.
Proprietary tubes without added exogenous substances. Moldable and suturable Patch-CGF with constant release of growth factors for over 14 days.
Trusted by Professionals
400+
Clinical Cases Managed
100+
Active Medical Professionals
70+
Partner Medical Centers
Kit Range
Download the complete product brochure
All technical details — Vulnology and Specialty Line.
Not a single burst. A 14-day biological program.
10x
VEGF vs previous generation
2x
TGF-β1 vs previous generation
Days 1–3: Activation
TNF-α triggers immediate platelet degranulation and repair cascade initiation.
Days 3–7: Proliferation
PDGF, TGF-β1 sustain cell proliferation, collagen synthesis and ECM deposition.
Days 7–14: Remodeling
VEGF, BMP-2 drive angiogenesis, new vessel formation and tissue maturation.
Therapeutic Areas
One system. Multiple specialties.
Advanced Wound Care
CGF Patch — a 14-day biological program
Dense 3D fibrin matrix. 89% healing in 15-120 days. Moldable, suturable, fully resorbable.
Orthopedics
Injectable E-PRP & Sticky Bone
4-5x platelet concentration, fully depleted of pro-inflammatory components. Algorithm-optimized for joint infiltration.
General Surgery
Colorectal Surgery E-PRP + Patch-CGF — biological obliteration of the tract. Luminal infiltration plus sutured fibrin scaffold to reduce dead space.
Pain Management
Injectable E-PRP — steroid-free analgesia. Multi-target action without tissue catabolism. Repeatable cycles, ultrasound-guided.
Reproductive Medicine
Intrauterine & vulvar E-PRP — dual indication. Endometrial preparation pre-transfer and regenerative protocol for vulvar lichen sclerosus.
Hair Restoration
E-PRP — dermal papilla reactivation. Intradermal microinjections for androgenetic alopecia within a multimodal protocol.
Clinical Hub
Evidence that speaks for itself.
Distribution Network
Grow with High Q Cell
We partner with qualified distributors across Europe, providing technical and commercial support for advanced regenerative medicine.